Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center Laura Kooistra, BS, Claudia Ricotti, BS, Fabrizio Galimberti, MD, Carmen Gota, MD, Anthony P. Fernandez, MD, PhD Journal of the American Academy of Dermatology Volume 79, Issue 1, Pages 152-155 (July 2018) DOI: 10.1016/j.jaad.2018.01.002 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Patients with malignancies diagnosed within 3 years of DM diagnosis, 2004-2016. Of 73 malignancy-associated DM patients (excluding common, nonmelanoma skin cancer), 50 (68.5%) developed malignancy within 3 years of DM diagnosis. Malignancy distribution of 50 patients: 9 lung, 7 colon, 6 breast, 5 hematologic, 4 oropharyngeal, 4 ovarian, 4 renal, 3 thyroid, 2 esophageal, 2 prostate, 1 thymic, 1 melanoma, 1 gastric, and 1 testicular. DM, Dermatomyositis. Journal of the American Academy of Dermatology 2018 79, 152-155DOI: (10.1016/j.jaad.2018.01.002) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions